Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BML Pharmaceuticals

1996 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of proprietary prescriptive pharmaceutical products in the areas of cancer treatment. The company's products are formulated into therapeutics which range from the prevention and treatment of dermal disease to mucositis for cancer patients.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1129 Northern Boulevard
  • Suite 406
  • Manhasset, NY 11030
  • United States

BML Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BML Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

BML Pharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore BML Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

BML Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Barry Libin Chairman & Chief Executive Officer

BML Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
00000 00000 Self Chairman & Chief Executive Officer 000 0000